Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             188 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A bis(thiosemicarbazone) bifunctional chelating agent for nitrido-technetium-99m and copper-64 based radiopharmaceuticals Salvarese, N.
2019
112-113 S1 p. S28
artikel
2 A clinical introduction of somatostatin receptor (SSTR) imaging with 68Ga-DOTATOC PET/TC Agostini, S.
2019
112-113 S1 p. S46
artikel
3 A clinical overview of pheochromocytomas/paragangliomas and carcinoid tumors Ilias, Ioannis
2008
112-113 S1 p. S27-S34
8 p.
artikel
4 A comparison of chelate labeling with Ac-225: application to PSMA-targeting radiopharmaceuticals Kelly, J.
2019
112-113 S1 p. S11
artikel
5 Ac-225 vs Lu-177 radioimmunoconjugates in vitro and in vivo Lakes, A.
2019
112-113 S1 p. S15
artikel
6 A 68Ga-labelled PET probe for selective imaging of αvβ8-integrin Notni, J.
2019
112-113 S1 p. S18-S19
artikel
7 An alternative separation strategy for the isolation of Ac and Ra isotopes from thorium targets irradiated with high energy protons Baimukhanova, A.
2019
112-113 S1 p. S32
artikel
8 A new approach for labelling near-infrared dyes with 99mTc for combined SPECT and photoacoustic imaging of calcium accretion Slikboer, S.
2019
112-113 S1 p. S2
artikel
9 A new family of tacn derivatives for 64Cu and 68Ga chelation Denat, F.
2019
112-113 S1 p. S11-S12
artikel
10 A platform for delivery of small molecules using trans-cyclooctene-functionalized pluronic F127 micelles Ahmad, Z.
2019
112-113 S1 p. S64
artikel
11 A proof of concept study with FSC-based hybrid imaging agents for pretargeting applications Summer, D.
2019
112-113 S1 p. S33-S34
artikel
12 A remotely controlled module for an in-hospital routine production of Tc-99m by medical cyclotrons Boschi, A.
2019
112-113 S1 p. S47
artikel
13 A series of radiolabeled mannosylated dextran derivatives for sentinel lymph node detection Papasavva, A.
2019
112-113 S1 p. S29
artikel
14 Assessment of 99mTc/186Re-tricarbonyl-NODAGA and NOTA complexes in the design of radiolabeled somatostatin receptor-targeting agents Makris, G.
2019
112-113 S1 p. S24
artikel
15 Automated production of Cu-64, Zr-89, Ga-68, Ti-45, I-123 and I-124 with a medical cyclotron, using a commercial solid target system Malinconico, M.
2019
112-113 S1 p. S6
artikel
16 A versatile immune-stimulatory radiometal complex for combination radiotherapy and immunotherapy Rathmann, S.
2019
112-113 S1 p. S12-S13
artikel
17 Barium ferrite nanoparticles labeled with 223Ra: a new potential radiobioconjugate for internal alpha therapy and magnetic hyperthermia Gaweda, W.
2019
112-113 S1 p. S37
artikel
18 Bifunctional cyclam derivatives with a bis(phosphinate) pendant arm as efficient chelators for copper radionuclides Pietzsch, H.J.
2019
112-113 S1 p. S40
artikel
19 Bifunctional dendrimer scaffold leads to increased tumor uptake Cook, B.
2019
112-113 S1 p. S16
artikel
20 Bimodal prostate specific membrane antigen ligands for intra-operative tumor detection and photodynamic therapy of prostate cancer Derks, Y.
2019
112-113 S1 p. S14
artikel
21 Bioconjugated gold nanoparticles for cancer theranostics Silva, F.
2019
112-113 S1 p. S52
artikel
22 Bioconjugates of gold nanoparticles with trastuzumab labelled with 211At for alpha nanobrachyterapy Dziawer, L.
2019
112-113 S1 p. S64
artikel
23 Bio-inspired peptoid chelators for imaging and targeted alpha therapy Rees, J.
2019
112-113 S1 p. S45
artikel
24 Biological profile of 111In-SB9, a new GRPR-antagonist radioligand for prostate cancer imaging: the role of neprilysin on tumor targeting efficacy in mice Maina, Th.
2019
112-113 S1 p. S53
artikel
25 Bisarene complexes of 99mTc and Re: Developing a new platform for imaging and (radio) therapy Braband, H.
2019
112-113 S1 p. S1-S2
artikel
26 Bis(diphosphino)maleic anhydride as a bifunctional chelator for technetium-99m Hungnes, I.
2019
112-113 S1 p. S25-S26
artikel
27 Calix[4]crown-6 scaffold for the complexation of barium and radium Mamat, C.
2019
112-113 S1 p. S14
artikel
28 Click chemistry: an efficient strategy for the labeling of proteins Lodhi, N.A.
2019
112-113 S1 p. S4
artikel
29 “Click to ligand/conjugate” for facile labeling with Al[18F]F, 68Ga, 111In or 64Cu Walther, M.
2019
112-113 S1 p. S35
artikel
30 Combined radio- and immunotherapy treatments for triple-negative breast cancer Vito, A.
2019
112-113 S1 p. S22
artikel
31 Comparative evaluation of anti-EGFR affibody molecules labelled with gallium-68 and zirconium-89 using DFO chelator Maryam, O.
2019
112-113 S1 p. S66
artikel
32 Comparative radium-223 labeling with NOTA and DOTA-somatostatin derivatives for a potential use in targeted cancer therapy Riondato, M.
2019
112-113 S1 p. S50-S51
artikel
33 Comparison of the IGG-100 vs the ITG 68Ge/68Ga generators: impact of impurities on radiolabeling Amor-Coarasa, A.
2019
112-113 S1 p. S47-S48
artikel
34 Controlling technetium-99 oxidation states under legacy waste and environmental conditions Francesconi, L.
2019
112-113 S1 p. S25
artikel
35 Copper-64 and fluorescein labeled anti-miRNA peptide nucleic acids for the detection of miRNA expression in living cells Croci, S.
2019
112-113 S1 p. S44
artikel
36 Cross-bridged cyclams with bis (phosphinic acid) pendants for a fast Cu(II) complexation: towards efficient 64Cu labeling Kubicek, V.
2019
112-113 S1 p. S10-S11
artikel
37 64Cu radiolabeling of polymeric micellar nanoparticles Mattingly, S.
2019
112-113 S1 p. S61
artikel
38 Current experience with mIBG therapy in combination with chemotherapy and radiosensitizers Gaze, Mark N.
2008
112-113 S1 p. S21-S26
6 p.
artikel
39 Cyclopentadienyl tricarbonyl 99mTc/Re complexes containing spirocyclic piperidine moiety as nonselective sigma receptor ligands for tumor imaging and therapy Wang, X.
2019
112-113 S1 p. S6
artikel
40 Cyclotron-based production of Tc-99m and other metals Schaffer, P.
2019
112-113 S1 p. S6-S7
artikel
41 Desmin- and vimentin-targeting tracer 99mTc-GlcNAc-PEI for idiopathic pulmonary fibrosis imaging with SPECT/CT in a mice model Zhang, D.
2019
112-113 S1 p. S29
artikel
42 Deuterium isotopic substitution in 64CuATSM: effects on redox potential and hypoxic trapping Blower, J.
2019
112-113 S1 p. S42
artikel
43 Developing radioimmunotherapy of osteosarcoma using comparative oncology approach Dadachova, E.
2019
112-113 S1 p. S21
artikel
44 Development and characterization of a 177Lu-labeled anti-prostate stem cell antigen (PSCA) monoclonal antibody for metastatic prostate cancer Striese, F.
2019
112-113 S1 p. S20
artikel
45 Development and evaluation of a 99mTc(III) ‘4 + 1’ complex derived from estradiol for imaging breast cancer Tejeria, M.E.
2019
112-113 S1 p. S4
artikel
46 Development of a MUC1-targeting PET probe for ovarian cancer Fung, K.
2019
112-113 S1 p. S57-S58
artikel
47 Development of FR-targeting agent for SPECT imaging of atherosclerosis Xuejun, W.
2019
112-113 S1 p. S66-S67
artikel
48 Development of 68Ga-labelled tetrazines for pretargeted tumour imaging with PET Edem, P.
2019
112-113 S1 p. S57
artikel
49 Development of 99mTc-labeled tetrazines with favorable brain pharmacokinetics for bioorthogonal SPECT imaging Zhang, X.
2019
112-113 S1 p. S3
artikel
50 Development of scandium-exopolysaccharide complexes as a theranostic tool in bone oncology Mazza, M.
2019
112-113 S1 p. S22-S23
artikel
51 Diagnosis and therapy of carcinoid tumors—current state of the art and future directions Khan, Mazhar U.
2008
112-113 S1 p. S77-S91
15 p.
artikel
52 Direct isolation of 89Zr-chloride using a solid-phase tributyl phosphate resin Graves, S.
2019
112-113 S1 p. S14-S15
artikel
53 Drug formulation and its impact on the distribution of [99mTc] Tc-tetrazines for pretargeting applications via inverse-electron demand Diels-Alder chemistry Bilton, H.
2019
112-113 S1 p. S26
artikel
54 Dual modal fluorescence/SPECT imaging probes: 4-Amino-1,8-naphthalimide 99mTc/Re-tricarbonyl complexes Murrell, E.
2019
112-113 S1 p. S2
artikel
55 Dual-modality liver function imaging agent: neolactosylated albumin stabilized gold nanoclusters Xue, J.
2019
112-113 S1 p. S41-S42
artikel
56 Effect of the radiometal on the pharmacokinetics of a PSMA-targeting ligand for radioligand therapy Kelly, J.
2019
112-113 S1 p. S54
artikel
57 Efficacy of 44Sc production from natural calcium Wojdowska, W.
2019
112-113 S1 p. S32
artikel
58 Enhancing PET signal at target tissue in vivo: dendritic hydroxypyridinone peptide conjugates for molecular imaging with gallium-68 Ma, M.
2019
112-113 S1 p. S12
artikel
59 Evaluating HOPO chelators with therapeutic radioisotopes for theranostic applications in immunoPET imaging and radioimmunotherapy Tully, K.
2019
112-113 S1 p. S49
artikel
60 Evaluation of a somastostatin receptor based theranostic agent with an albumin binding via structural modifications using a truncated Evans Blue molecule Bandara, N.
2019
112-113 S1 p. S21
artikel
61 Evaluation of Ga-68-DOTA-GGNle-CycMSHhex for melanoma imaging Yang, J.
2019
112-113 S1 p. S34-S35
artikel
62 Evaluation of [99mTc]Tc(CO)3 + moiety labeled alpha-melanocyte stimulating hormone derived peptide conjugates for potential melanoma imaging Weissflog, S.
2019
112-113 S1 p. S55
artikel
63 Evaluation of [227Th]thorium chelation of hydroxypyridinone- and picolinic acid-containing ligands to simulate 226Th chelation Li, Y.
2019
112-113 S1 p. S38
artikel
64 Fully automated zirconium-89 antibody labeling and purification Vugts, D.
2019
112-113 S1 p. S23
artikel
65 68Ga- and 177Lu-radiolabelling chemistry of DO3A-VS-Cys40-Exendin-4 and differences of the tracer pancreatic uptake in various species Velikyan, I.
2019
112-113 S1 p. S55
artikel
66 68Ga-curcumin-based bifunctional ligands for Alzheimer’s disease diagnosis Orteca, G.
2019
112-113 S1 p. S43-S44
artikel
67 68Ga labelled bacterial siderophore for infection imaging: a proof of principle Zhai, C.
2019
112-113 S1 p. S62
artikel
68 68Ga-labelled, fluorescent siderophores: dual imaging potential in Aspergillus fumigatus infections Kochinke, L.
2019
112-113 S1 p. S62-S63
artikel
69 68Ga labelling of a 12-mer peptide selective for tissue transglutaminase 2 Ackermann, U.
2019
112-113 S1 p. S41
artikel
70 Heterobivalent bioconjugates based on the FSC-scaffold targeting folate receptor and alphavbeta3 integrin Kaeopookum, P.
2019
112-113 S1 p. S37-S38
artikel
71 Host-guest based pretargeting with 89Zr- and 177Lu-labeled adamantane based radioligands Jallinoja, V.
2019
112-113 S1 p. S65
artikel
72 Imaging folate-receptor expression using 55Co-labeled albumin-binding folic acid derivatives Fernandez, S.
2019
112-113 S1 p. S58
artikel
73 Imaging the third gasotransmitter hydrogen sulfide using a 99mTc-labeled polyhydroxy weak acid Jeong, J.
2019
112-113 S1 p. S53-S54
artikel
74 Immuno-PET imaging of human tumor necrosis factor alpha in a transgenic mouse model of rheumatoid arthritis Beckford, V.
2019
112-113 S1 p. S16-S17
artikel
75 Improving excretory pathways of technetium-99m SPECT imaging agents based on bioorthogonal Diels-Alder click chemistry Walsh, J.
2019
112-113 S1 p. S65
artikel
76 Indium(III) complex with a bifunctional agent for dual targeting of cancer cells Vultos, F.
2019
112-113 S1 p. S44
artikel
77 Influence of treatment with antimicrobial agents in the diagnosis of microbiological infections with technetium-99m labelled caspofungin Bentura, M.
2019
112-113 S1 p. S55-S56
artikel
78 Investigation of the effect of trace metals on radiolabelling tris(3-hydroxy-4-pyridinone) with 68Ga Cusnir, R.
2019
112-113 S1 p. S41
artikel
79 In vitro and in vivo evaluation of novel 89Zr chelators Denat, F.
2019
112-113 S1 p. S44-S45
artikel
80 In vitro preliminary study of 64Cu-labeled anti-CD20 mAb for pretargeted immuno-PET Kim, H.
2019
112-113 S1 p. S64
artikel
81 In vitro studies of Bi2S3 nanoparticles as radiosensitizer in MCF7 cells Galain, I.
2019
112-113 S1 p. S51-S52
artikel
82 In vivo assessment of 99mTc-labeled CCR2-binding peptide in a mouse model of myocardial infarction Lee, W.
2019
112-113 S1 p. S18
artikel
83 Isolation of 99mTc from the gamma/proton irradiated 100Mo target Gumiela, M.
2019
112-113 S1 p. S30
artikel
84 Labeling of a drug delivery system based on carbon nanotubes with 68Ga and 64Cu: an in vivo biodistribution study Gammon, S.
2019
112-113 S1 p. S38-S39
artikel
85 LARAMED: a LAboratoty of RAdioisotopes for MEDicine Martini, P.
2019
112-113 S1 p. S30-S31
artikel
86 LC-MS and MALDI-TOF supported metabolism studies of the selective alphavbeta3 RGDechi peptide and of the corresponding [99mTc(N)PNP]-tagged derivatives Bolzati, C.
2019
112-113 S1 p. S63-S64
artikel
87 Ligand development for the Radiometal Hg-197(m) Gilpin, I.
2019
112-113 S1 p. S37
artikel
88 Linking computational, spectroscopic, and radiochemical methods to design the next-generation of radiometal chelators Khozeimeh, A.
2019
112-113 S1 p. S34
artikel
89 177Lu-labelled peptidomimetics: novel minigastrin analogues for improved tumour targeting Grob, N.
2019
112-113 S1 p. S20
artikel
90 Lu-177 radiolabeled ultrasmall C’ dot nanoparticle melanoma theranostics Chen, F.
2019
112-113 S1 p. S60
artikel
91 Manganese carbonyl derivatives as CO source for preparation of [99mTc(CO)3(H2O)3]+ Yang, W.
2019
112-113 S1 p. S25
artikel
92 Medically interesting radiolanthanide terbium-161: from production towards clinical application Gracheva, N.
2019
112-113 S1 p. S8-S9
artikel
93 Meta[131I]iodobenzylguanidine therapy for patients with metastatic and unresectable pheochromocytoma and paraganglioma Goldsby, Robert E.
2008
112-113 S1 p. S49-S62
14 p.
artikel
94 Meta-iodobenzyl guanidine for detection and staging of neuroendocrine tumors Pryma, Daniel
2008
112-113 S1 p. S3-S8
6 p.
artikel
95 Metaiodobenzylguanidine in the diagnosis and therapy of neuroendocrine tumors Coleman, R. Edward
2008
112-113 S1 p. S1-
1 p.
artikel
96 Microfluidic synthesis of [177Lu]Lu-DOTA-TATE De Zanger, R.
2019
112-113 S1 p. S50
artikel
97 Moving towards clinical translation of bioorthogonal chemistry: preparation and testing of a 99mTc instant kit for imaging and treating bone injury using inverse-electron demand Diels-Alder (IEDDA) chemistry Mercanti, N.
2019
112-113 S1 p. S30
artikel
98 99mTc-DGA1, a new radiotracer derived from a non-peptidic CCK2R-antagonist, showing excellent prospects for diagnostic imaging of CCK2R-positive human tumors with SPECT Maina, Th.
2019
112-113 S1 p. S52-S53
artikel
99 99mTc-labeled triphenyl phosphonium cations as potential metallic diagnostic agents for multidrug resistance Li, X.
2019
112-113 S1 p. S58
artikel
100 99mTc-labeled zinc-dipicolylamine complex for cell death imaging Ogawa, K.
2019
112-113 S1 p. S61
artikel
101 [99mTc]Tc-HYNIC-MGS5 and [68Ga]Ga-DOTA-MGS5: two novel imaging probes for cholecystokinin-2 receptor targeting Klingler, M.
2019
112-113 S1 p. S16
artikel
102 99mTechnetium site-specific labeling of S-alkylated homodimeric N-acetyl cysteine ethyl ester(NACET) DTPA derivative for neuro imaging Hazari, P.
2019
112-113 S1 p. S58-S59
artikel
103 Nanoprobes for nuclear imaging and/or therapy: how FFF techniques could characterize these nanometric scaffolds Huclier-Markai, S.
2019
112-113 S1 p. S36-S37
artikel
104 Neuropeptide Y short analogue as potential breast cancer diagnostic and therapeutic agent Tejeria, M.E.
2019
112-113 S1 p. S23
artikel
105 Neutral fac-[Re(I)/Tc(I)(CO)3(PO)L] complexes with substituted pyridine as a monodentate ligand Vlastara, M.
2019
112-113 S1 p. S28
artikel
106 Neutral oxorhenium(V) complexes of an N3S donor set that bind to amyloid-beta plaques Spyrou, B.
2019
112-113 S1 p. S30
artikel
107 New bifunctional chelators for diagnostic and therapeutic radioisotopes Li, L.
2019
112-113 S1 p. S10
artikel
108 New library of ligands for radiometals Boninsegni, A.
2019
112-113 S1 p. S38
artikel
109 New 52Mn complexes for cell labelling and liposome tracking with PET Gawne, P.
2019
112-113 S1 p. S35-S36
artikel
110 New neutral and cationic “2+1” Re/99mTc(CO)3 complexes with 1,3,5-triaza-7-phosphaadamantane and its N-benzyl derivative Ischyropoulou, M.
2019
112-113 S1 p. S27-S28
artikel
111 New tricarbonylrhenium(I) complexes: from structural study to a potential therapeutic radiopharmaceutical to target hepatocellular carcinoma metastases Eychenne, R.
2019
112-113 S1 p. S4
artikel
112 Novel 4-nitroimidazole isocyanide labelled with 99mTc(I) core and [99mTc(I)(CO)3]+ core as potential tumor hypoxia imaging agents Ruan, Q.
2019
112-113 S1 p. S62
artikel
113 Optimizing MIBG therapy of neuroendocrine tumors: preclinical evidence of dose maximization and synergy Mairs, Rob J.
2008
112-113 S1 p. S9-S20
12 p.
artikel
114 Organometallic 99mTc/186Re-NOTA and NODAGA complexes utilizing a GRPR-targeting peptide antagonist Makris, G.
2019
112-113 S1 p. S3-S4
artikel
115 Overcoming challenges for immunoreactivity assessment of radiolabeled antibodies Beckford, V.
2019
112-113 S1 p. S52
artikel
116 Overcoming immune-barrier: cell membrane cloaked zirconium-89 hollow mesoporous silica nanospheres Jun Young, Y.
2019
112-113 S1 p. S43
artikel
117 PET-MR amenable theranostic perfluorocarbon nanoemulsion for targeting inflammation Nyiranshuti, L.
2019
112-113 S1 p. S38
artikel
118 Photonuclear production of high specific activity copper-67 and scandium-47 Rotsch, D.
2019
112-113 S1 p. S7
artikel
119 Photoreduction of Tc-99 pertechnetate to Tc (IV) by polyoxometalates and titanium dioxide and speciation of stabilized Tc(IV) Burton-Pye, B.
2019
112-113 S1 p. S5
artikel
120 PLGA nanoparticles for combined SPECT/PET and 19F MRI in vivo cell tracking Krekorian, M.
2019
112-113 S1 p. S42-S43
artikel
121 Polymersomes in alpha radionuclide therapy De Kruijff, R.
2019
112-113 S1 p. S9
artikel
122 Pre-clinical evaluation of 225Ac-DOTATOC pharmacokinetics, dosimetry, and toxicity to enable Phase-1 clinical trial in patients with neuroendocrine tumors Norenberg, J.
2019
112-113 S1 p. S60
artikel
123 Preclinical evaluation of a [89Zr]-labeled elastin-specific tracer for imaging of pulmonary fibrosis Burkemper, J.
2019
112-113 S1 p. S19
artikel
124 Preclinical evaluation of 64Cu-labeled monomeric and trimeric (RGDfK) conjugates based on a novel chelating platform Bartholomä, M.
2019
112-113 S1 p. S18
artikel
125 Preliminary study on 64Cu-labeled tetraiodothyroacetic acid derivative for tumor angiogenesis imaging Choe, Y.
2019
112-113 S1 p. S56
artikel
126 Pretargeted 225Ac-radioimmunotherapy of pancreatic ductal adenocarcinoma: evaluating DNA-damage with 89Zr-PET Poty, S.
2019
112-113 S1 p. S15-S16
artikel
127 Production of 225Ac and 225Ra for targeted alpha therapy via spallation on thorium: overview of radiochemical strategies and need for separation from large thorium targets Radchenko, V.
2019
112-113 S1 p. S5
artikel
128 Production of a 52Mn-labeled PSMA-selective bimodal PET/MR probe Giesen, K.
2019
112-113 S1 p. S13
artikel
129 Production of emerging positron emitting radiometal zirconium-89 with RFT-30 cyclotron Vyas, C.
2019
112-113 S1 p. S32-S33
artikel
130 Production of 47Sc on 48Ca targets Walczak, R.
2019
112-113 S1 p. S48
artikel
131 Production, purification and use of 66Ga for “in vivo” screening of therapeutic compounds Amor-Coarasa, A.
2019
112-113 S1 p. S31
artikel
132 Prospects for Sc-47 production in nuclear reactor Zoltowska, M.
2019
112-113 S1 p. S7
artikel
133 Quantification of inhaled aerosol particles composed of toxic disinfectant by using radioanalytical method Jeon, J.
2019
112-113 S1 p. S43
artikel
134 Quantitative assessment of fluorescence uptake by dual labeling Azhdarinia, A.
2019
112-113 S1 p. S54
artikel
135 Radioiodinated MIBG in paraganglioma and pheochromocytoma: previous results and early experiences using no-carrier-added MIBG James, Olga
2008
112-113 S1 p. S63-S76
14 p.
artikel
136 Radiolabeled metaiodobenzylguanidine for the treatment of neuroblastoma DuBois, Steven G.
2008
112-113 S1 p. S35-S48
14 p.
artikel
137 Radiolabeling and proof-of-principle in vivo studies using actinium-225 produced at TRIUMF’s isotope separation on-line facility Ramogida, C.
2019
112-113 S1 p. S9-S10
artikel
138 Radiometal-labeled bombesin derivatives for preclinical imaging Ferguson, S.
2019
112-113 S1 p. S35
artikel
139 Radiopharmacological evaluation of novel 68Ga labeled peptide conjugates for potential use in imaging of gliomas Lu, G.
2019
112-113 S1 p. S48
artikel
140 188Re-SSS/Lipiodol for HCC treatment: from (radio)chemistry to preliminary clinical results Lepareur, N.
2019
112-113 S1 p. S46
artikel
141 Rhenium(I) DNA-intercalating complexes as anticancer agents Kaplanis, M.
2019
112-113 S1 p. S24
artikel
142 44Sc-labeling of RM2 as potential imaging and dosimetry agent of prostate cancer Eppard, E.
2019
112-113 S1 p. S45
artikel
143 47Sc targetry: investigating the production of 47Sc from 48Ti toward use in targeted radiotherapy Phipps, M.
2019
112-113 S1 p. S33
artikel
144 Selective detection of alphavbeta3 integrin receptors using [99mTc(N)PNP]-labelled RGDechi peptides Bolzati, C.
2019
112-113 S1 p. S56-S57
artikel
145 Speciation of technetium-99 in ionic liquids Hatcher, J.
2019
112-113 S1 p. S26-S27
artikel
146 SPECT/CT imaging of cancer stem cells in aggressive prostate cancer using a 67Ga labeled anti-CD44v6 antibody Prater, A.
2019
112-113 S1 p. S17
artikel
147 Supramolecular interaction of caffeine molecules with each other, water molecules and oxygen atoms in the cobalt, cadmium and magnesium perrhenates of caffeine German, K.
2019
112-113 S1 p. S26
artikel
148 Synthesis and biodistribution of 99mTc(CO)3-CPA-2NM as a novel tumor hypoxia imaging agent Lin, X.
2019
112-113 S1 p. S23-S24
artikel
149 Synthesis and biological evaluation of 99mTc-ATRIDAT-methoxyphenylpiperazine radioligand for 5-HT1A receptor imaging Mishra, A.
2019
112-113 S1 p. S59
artikel
150 Synthesis and characterization of Re(CO)3 + and 99mTc(CO)3 + dithiocarbamate-isocyanide “2 + 1” mixed ligand complexes using [Cu(MIBI)4]BF4 Makrypidi, K.
2019
112-113 S1 p. S66
artikel
151 Synthesis and characterization of rhenium(III) complexes with pincer-like PNP(R) ligands Salvarese, N.
2019
112-113 S1 p. S5-S6
artikel
152 Synthesis and evaluation of a fac-[Re(CO)3]+ complex bearing 2-(4’-aminophenyl)benzothiazole as anticancer agent Mavroidi, B.
2019
112-113 S1 p. S50
artikel
153 Synthesis and evaluation of a 99mTc(CO)3-labelled palbociclib derivative to target cyclin-dependent kinase 4/6 for tumor imaging Song, X.
2019
112-113 S1 p. S61
artikel
154 Synthesis and evaluation of a 99mTc-labeled hexavalent targeting probe from a monovalent ligand for in vivo imaging of saturable systems Mizuno, Y.
2019
112-113 S1 p. S3
artikel
155 Synthesis and evaluation of 99mTc-HYNIC-RM2: a novel SPECT based gastrin releasing peptide receptor antagonist Vats, K.
2019
112-113 S1 p. S29
artikel
156 Synthesis and evaluation of [2+1] Re(I)/Tc(I) complexes as isostructural optical and nuclear probes for imaging prostate cancer Yazdani, A.
2019
112-113 S1 p. S27
artikel
157 Synthesis and labelling of a phenylboranate derivative with 68Ga for molecular recognition of overexpressed sialic acid on tumor cells Shegani, A.
2019
112-113 S1 p. S40
artikel
158 Synthesis, characterization and in vitro biological assessment of novel mixed “2 + 1” rhenium (i) complexes with a benzothiazole derivative Roupa, I.
2019
112-113 S1 p. S1
artikel
159 Synthesis, characterization and labeling of [64Cu]-5-(4-aminophenyl)-10,15,20-triphenyl porphyrine as a potential PET imaging chelate Aguilar-Ortiz, E.
2019
112-113 S1 p. S36
artikel
160 Synthesis of bifunctional HBED-based complexing ligands for use in theragnostic radiopharmaceuticals Makarem, A.
2019
112-113 S1 p. S40-S41
artikel
161 Synthesis of rhenium and technetium N2O2 Schiff base complexes Baumeister, J.
2019
112-113 S1 p. S27
artikel
162 Synthesis of [99TcX(CO)5] (X = Cl, Br, I) at ambient pressure Miroslavov, A.
2019
112-113 S1 p. S24
artikel
163 Synthesis of triphenylphosphonium cation and folic acid conjugated 89Zr-labeled silica nanoparticles for cancer imaging agent Park, J.
2019
112-113 S1 p. S51
artikel
164 Synthesis, stability, and in vivo imaging of the indirect incorporation of arsenic-72 on therapeutic antibodies Kim, J.
2019
112-113 S1 p. S45-S46
artikel
165 Targeted radiopharmaceuticals for nuclear imaging and radiotherapy of CD133-positive tumors Wyszatko, K.
2019
112-113 S1 p. S49
artikel
166 Targeting CD38 for theranostics of lymphoma with 89Zr and 177Lu Cai, W.
2019
112-113 S1 p. S17
artikel
167 Targeting the GLP-1 receptor on pancreatic beta-cells: signaling and radiopharmaceutical applications Käppeli, S.
2019
112-113 S1 p. S54-S55
artikel
168 Teaching old ligands new tricks: macrocyclic chelators for zirconium-89 radiochemistry Henry, K.
2019
112-113 S1 p. S15
artikel
169 Technetium-99m labeled phenylquinoxaline derivatives as potential tau-selective imaging probes for diagnosis of Alzheimer’s disease Yang, F.
2019
112-113 S1 p. S56
artikel
170 Technetium-99m radiolabeled glucagon-like peptide analog exendin-4 for cancer diagnosis Ozgenc, E.
2019
112-113 S1 p. S49-S50
artikel
171 TECHN-OSP: Molybdenum target preparation techniques for cyclotron-based technetium-99m production Skliarova, H.
2019
112-113 S1 p. S8
artikel
172 Tetrakis(3,4-hydroxypyridinone) bifunctional chelators for zirconium-89 imaging of antibodies Morais, M.
2019
112-113 S1 p. S34
artikel
173 The application of polyoxometalates to thorium debulking studies for actinium-225 production Hatcher, J.
2019
112-113 S1 p. S20-S21
artikel
174 The efficacy of the available peptide receptor radionuclide therapy for neuroendocrine tumors: a meta-analysis Dannoon, S.
2019
112-113 S1 p. S48
artikel
175 The optimization of click-mediated pretargeted radioimmunotherapy Membreno, R.
2019
112-113 S1 p. S17-S18
artikel
176 The possibility of producing 43Sc from 44Ca via the (p,2n) nuclear reaction Van der Meulen, N.
2019
112-113 S1 p. S9
artikel
177 Theranostic 203/212Pb-labeled octreotate analogs (AlphaMedix TM) and their preclinical characterization for the Phase I clinical studies in neuroendocrine cancer patients Tworowska, I.
2019
112-113 S1 p. S19-S20
artikel
178 Theranostics of angiogenic tumors with 86/90Y-labeled antibodies Ehlerding, E.
2019
112-113 S1 p. S59
artikel
179 Title Page 2019
112-113 S1 p. iii
artikel
180 Trastuzumab co-treatment improves survival of mice with PC-3 prostate cancer xenografts treated with [177Lu]Lu-DOTAGA-PEG2-RM26 GRPR antagonists Mitran, B.
2019
112-113 S1 p. S21-S22
artikel
181 1,4,7-Triazacyclononane: an effective chelator for copper-64 Kubeil, M.
2019
112-113 S1 p. S13-S14
artikel
182 Ultrasmall silicon nanoparticles as promising platform for targeted multimodal imaging Zarschler, K.
2019
112-113 S1 p. S59-S60
artikel
183 US DOE tri-lab effort to produce actinium-225 Cutler, C.
2019
112-113 S1 p. S8
artikel
184 Use of magnetron sputtering technique for medical cyclotron solid target preparation Skliarova, H.
2019
112-113 S1 p. S31
artikel
185 What was it like to hit upon the “Theragnostics” Paradigm: “A Personal Journey” at Brookhaven National Laboratory Srivastava, S.
2019
112-113 S1 p. S47
artikel
186 89Zr-atezolizumab conjugation strategies Carney, B.
2019
112-113 S1 p. S65-S66
artikel
187 89Zr-incorporated iron oxide nanocluster by chelator-free simple direct-labelling method for PET diagnosis Choi, P.
2019
112-113 S1 p. S63
artikel
188 [89Zr]Zirconium: dissolution and purification process based on commercial, cassette base, synthesis module Cazzola, E.
2019
112-113 S1 p. S33
artikel
                             188 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland